Anaconda Biomed
Anaconda Biomed is an innovative medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke.
At the heart of its product portfolio is the ANA Funnel Catheter which is designed to assist in neurovascular procedures by facilitating the delivery of other intravascular devices (i.e., stent retriever devices). The device consists of a radiopaque braid covered with a polymeric coating to enable local flow arrest. The catheter is currently an investigational device and is not available for sale in the United States or the European Union.
Anaconda Biomed has received funding from prominent life science investment firms, including Ysios Capital, Omega Funds, Innogest, Asabys Partners, Banco Sabadell, and private investors.
Additionally, through public grants, the company has received significant public support from ENISA, CDTI (Innvierte and NEOTEC), the Ministry of Science & Innovation (Emplea and Retos), EIB, and EIT Health.
